Extending the in vivo Half-Life of Adalimumab Fab via Sortase A-Mediated Conjugation of Adalimumab Fab with Modified Fatty Acids

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: Extending the in vivo Half-Life of Adalimumab Fab via Sortase A-Mediated Conjugation of Adalimumab Fab with Modified Fatty Acids ; volume:02 ; number:04 ; year:2020 ; pages:e160-e167
Pharmaceutical fronts ; 02, Heft 04 (2020), e160-e167

Contributor: Zhang, Qing-Bin
Ruan, Si-Da
Wu, Yong
Zhang, Jin-Hua
Lu, Jian-Guang
Feng, Jun

DOI: 10.1055/s-0041-1728817

URN: urn:nbn:de:101:1-2021080511472888485772

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:02 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Zhang, Qing-Bin
Ruan, Si-Da
Wu, Yong
Zhang, Jin-Hua
Lu, Jian-Guang
Feng, Jun

Other Objects (12)

Printed soft optical waveguides for delivering light into deep tissue

Printed soft optical waveguides for delivering light into deep tissue

Backbone and methyl side-chain resonance assignments of the Fab fragment of adalimumab

Backbone and methyl side-chain resonance assignments of the Fab fragment of adalimumab

Evolution trends of the 2009 pandemic influenza A (H1N1) viruses in different continents from March 2009 to April 2012

Evolution trends of the 2009 pandemic influenza A (H1N1) viruses in different continents from March 2009 to April 2012

Normative analysis of the paternity presumption in Article 1073 of the Civil Code of China

Normative analysis of the paternity presumption in Article 1073 of the Civil Code of China

Lighting the Path: Light Delivery Strategies to Activate Photoresponsive Biomaterials In Vivo

Lighting the Path: Light Delivery Strategies to Activate Photoresponsive Biomaterials In Vivo

Humira (Adalimumab) : Adalimumab in der Therapie der Psoriasis

Fallstudiensammlung

Humira (Adalimumab) : Adalimumab in der Therapie der Psoriasis

Fab. XI [-] Fab. XX

Abschnitt

Fab. XI [-] Fab. XX

Fab. LXXI. [-] Fab. LXXXII.

Abschnitt

Fab. LXXI. [-] Fab. LXXXII.

Fab. XI. [-] Fab. XX.

Abschnitt

Fab. XI. [-] Fab. XX.

Fab. XXI [-] Fab. XXX

Abschnitt

Fab. XXI [-] Fab. XXX

Fab. I. [Fab. C.]

Kapitel

Fab. I. [Fab. C.]

Fab. LI. [-] Fab. LX.

Abschnitt

Fab. LI. [-] Fab. LX.

Printed soft optical waveguides for delivering light into deep tissue

Printed soft optical waveguides for delivering light into deep tissue

Backbone and methyl side-chain resonance assignments of the Fab fragment of adalimumab

Backbone and methyl side-chain resonance assignments of the Fab fragment of adalimumab

Evolution trends of the 2009 pandemic influenza A (H1N1) viruses in different continents from March 2009 to April 2012

Evolution trends of the 2009 pandemic influenza A (H1N1) viruses in different continents from March 2009 to April 2012

Normative analysis of the paternity presumption in Article 1073 of the Civil Code of China

Normative analysis of the paternity presumption in Article 1073 of the Civil Code of China

Lighting the Path: Light Delivery Strategies to Activate Photoresponsive Biomaterials In Vivo

Lighting the Path: Light Delivery Strategies to Activate Photoresponsive Biomaterials In Vivo

Humira (Adalimumab) : Adalimumab in der Therapie der Psoriasis

Fallstudiensammlung

Humira (Adalimumab) : Adalimumab in der Therapie der Psoriasis

Fab. XI [-] Fab. XX

Abschnitt

Fab. XI [-] Fab. XX

Fab. LXXI. [-] Fab. LXXXII.

Abschnitt

Fab. LXXI. [-] Fab. LXXXII.

Fab. XI. [-] Fab. XX.

Abschnitt

Fab. XI. [-] Fab. XX.

Fab. XXI [-] Fab. XXX

Abschnitt

Fab. XXI [-] Fab. XXX

Fab. I. [Fab. C.]

Kapitel

Fab. I. [Fab. C.]

Fab. LI. [-] Fab. LX.

Abschnitt

Fab. LI. [-] Fab. LX.

Printed soft optical waveguides for delivering light into deep tissue

Printed soft optical waveguides for delivering light into deep tissue

Backbone and methyl side-chain resonance assignments of the Fab fragment of adalimumab

Backbone and methyl side-chain resonance assignments of the Fab fragment of adalimumab

Evolution trends of the 2009 pandemic influenza A (H1N1) viruses in different continents from March 2009 to April 2012

Evolution trends of the 2009 pandemic influenza A (H1N1) viruses in different continents from March 2009 to April 2012

Normative analysis of the paternity presumption in Article 1073 of the Civil Code of China

Normative analysis of the paternity presumption in Article 1073 of the Civil Code of China

Lighting the Path: Light Delivery Strategies to Activate Photoresponsive Biomaterials In Vivo

Lighting the Path: Light Delivery Strategies to Activate Photoresponsive Biomaterials In Vivo

Humira (Adalimumab) : Adalimumab in der Therapie der Psoriasis

Fallstudiensammlung

Humira (Adalimumab) : Adalimumab in der Therapie der Psoriasis

Fab. XI [-] Fab. XX

Abschnitt

Fab. XI [-] Fab. XX

Fab. LXXI. [-] Fab. LXXXII.

Abschnitt

Fab. LXXI. [-] Fab. LXXXII.

Fab. XI. [-] Fab. XX.

Abschnitt

Fab. XI. [-] Fab. XX.

Fab. XXI [-] Fab. XXX

Abschnitt

Fab. XXI [-] Fab. XXX

Fab. I. [Fab. C.]

Kapitel

Fab. I. [Fab. C.]

Fab. LI. [-] Fab. LX.

Abschnitt

Fab. LI. [-] Fab. LX.

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.